The week’s happenings:
- Cannabiz execs are increasingly optimistic New York will legalize REC this year.
MarketWatch - Senate Majority Leader Chuck Schumer (D-N.Y.) said cannabis reform is a priority.
Marijuana Moment - The Wall Street Journal‘s Heard on the Street column says pot stocks are “ready to roll.” (Paywall)
- However, November saw declines in year over year sales growth.
New Cannabis Ventures - The stock of Weedmaps’ parent company is on fire.
MJBiz - Bloomberg takes a look at the potential of delta-8 THC, the hemp-based cannabinoid that gets you high.
- A judge ruled MedMen must pay its former CFO at least $500,000 to cover his legal fees in an ongoing lawsuit against the company.
MJBiz - Dispensaries left the Commonwealth (Massachusetts) Dispensary Association, after the group sued the state to contest a policy that reserves delivery licenses for equity businesses.
Masslive - A leaked recording of Hadley Ford, former CEO of MSO iAnthus, conveys his perspective on an arrangement that will leave current shareholders with just 2.75% of the company.
New Cannabis Ventures - The New York Times takes a look at cannabis in Canada, two years after legalization.
- A study in the journal Nature says found CBD has important antimicrobial properties, which could have widespread implications for medicine.
